Evidence map›Paper›PMID 29023261›Full record

ArticleCritical care medicine2018

Prevention of Ventilator-Associated Pneumonia: The Multimodal Approach of the Spanish ICU "Pneumonia Zero" Program.

Francisco Álvarez-Lerma, Mercedes Palomar-Martínez, Miguel Sánchez-García, Montserrat Martínez-Alonso, Joaquín Álvarez-Rodríguez, Leonardo Lorente, Susana Arias-Rivera, Rosa García, Federico Gordo, José M Añón and 3 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06113939 (Prevention of Infection of the Respiratory Tract by Applying Methods That Are Non-Invasive for Extraction of Secretions. An Open Label, Randomized, Assessor-blinded Trial.), which is not on this map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06113939 phase4not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Prevention of Infection of the Respiratory Tract by Applying Methods That Are Non-Invasive for Extraction of Secretions. An Open Label, Randomized, Assessor-blinded Trial.

TypeinterventionalSponsorHospital San Carlos, MadridRan2026 to 2029Enrolled60ConditionsIntubation Complication, Stroke, Ischemic, Stroke Hemorrhagic, Head TraumaArmsairway clearance, subglottic secretion aspiration, Ceftriaxone 2 grams daily
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Francisco Álvarez-LermaService of Intensive Care Medicine, Spanish Society of Intensive and Critical Care Medicine and Research Group in Critical Disorders (GREPAC), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Coronary Units (SEMICYUC) Working Group on Infectious Diseases, Hospital del Mar, Parc de Salut Mar, Universitat Autònoma de Barcelona, Barcelona, Spain.
Mercedes Palomar-MartínezService of Intensive Care Medicine, SEMICYUC Working Group on Infectious Diseases, Hospital Universitari Arnau de Vilanova, Lleida, Spain.
Miguel Sánchez-GarcíaWorking Group on Infectious Diseases, SEMICYUC, Department of Critical Care, Hospital Clínico San Carlos, Madrid, Spain.
Montserrat Martínez-AlonsoUnit of Biostatistics, Institut de Reserca Biomèdica de Lleida (IRBLLEIDA), Universitat de Lleida (UdL), Lleida, Spain.
Joaquín Álvarez-RodríguezService of Intensive Care Medicine, SEMICYUC Working Group on Safety, Quality and Management, Hospital de Fuenlabrada, Fuenlabrada, Madrid, Spain.
Leonardo LorenteService of Intensive Care Medicine, SEMICYUC Working Group on Infectious Diseases, Hospital Universitario de Canarias, La Laguna, Santa Cruz de Tenerife, Spain.
Susana Arias-RiveraService of Intensive Care Medicine, Sociedad Española de Enfermería Intensiva y Unidades Coronarias (SEEIUC), Hospital Universitario de Getafe, Getafe, Madrid, Spain.
Rosa GarcíaService of Anesthesiology and Resuscitation, SEEIUC, Hospital Universitario de Basurto, Bilbao, Bizkaia, Spain.
Federico GordoService of Intensive Care Medicine, SEMICYUC Working Group on Acute Respiratory Insufficiency, Hospital Universitario del Henares, Colsada, Madrid, Spain.
José M AñónService of Intensive Care Medicine, SEMICYUC Working Group on Acute Respiratory Insufficiency, CIBER of Respiratory Diseases, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain.
Rosa Jam-GatellCritical Care Center, SEEIUC, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Tauli I3P3, Sabadell, Barcelona, Spain.
Mónica Vázquez-CalatayudArea of Nursing Research Training and Development, SEEIUC, Clínica Universidad de Navarra, Pamplona, Spain.
Yolanda AgraPatient Safety Unit, Spanish Ministry of Health, Social Policy and Equality, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThe "Pneumonia Zero" project is a nationwide multimodal intervention based on the simultaneous implementation of a comprehensive evidence-based bundle measures to prevent ventilator-associated pneumonia in critically ill patients admitted to the ICU.

designProspective, interventional, and multicenter study.

settingA total of 181 ICUs throughout Spain. PATIENTS: All patients admitted for more than 24 hours to the participating ICUs between April 1, 2011, and December 31, 2012.

interventionTen ventilator-associated pneumonia prevention measures were implemented (seven were mandatory and three highly recommended). The database of the National ICU-Acquired Infections Surveillance Study (Estudio Nacional de Vigilancia de Infecciones Nosocomiales [ENVIN]) was used for data collection. Ventilator-associated pneumonia rate was expressed as incidence density per 1,000 ventilator days. Ventilator-associated pneumonia rates from the incorporation of the ICUs to the project, every 3 months, were compared with data of the ENVIN registry (April-June 2010) as the baseline period. Ventilator-associated pneumonia rates were adjusted by characteristics of the hospital, including size, type (public or private), and teaching (postgraduate) or university-affiliated (undergraduate) status. MEASUREMENTS AND MAIN

resultsThe 181 participating ICUs accounted for 75% of all ICUs in Spain. In a total of 171,237 ICU admissions, an artificial airway was present on 505,802 days (50.0% of days of stay in the ICU). A total of 3,474 ventilator-associated pneumonia episodes were diagnosed in 3,186 patients. The adjusted ventilator-associated pneumonia incidence density rate decreased from 9.83 (95% CI, 8.42-11.48) per 1,000 ventilator days in the baseline period to 4.34 (95% CI, 3.22-5.84) after 19-21 months of participation.

conclusionsImplementation of the bundle measures included in the "Pneumonia Zero" project resulted in a significant reduction of more than 50% of the incidence of ventilator-associated pneumonia in Spanish ICUs. This reduction was sustained 21 months after implementation.

Indexed as

Critical CareHumansIntensive Care UnitsPneumonia, Ventilator-AssociatedPractice Guidelines as TopicProgram EvaluationProspective StudiesSpain

Identifiers

PMID29023261
PMCPMC5770104

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.